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A B S T R A C T
A case of focal inferior limb sensory-motor status epilepticus as the only manifestation of a multiple
sclerosis (MS) relapse is described. To obtain evidence of the relationship between the seizures, the
cortical plaque and the left foot motor area, an EEG–fMRI co-registration study was undertaken
demonstrating that seizure-related BOLD signal substantially overlapped with the inﬂammatory lesion
involving the foot sensory-motor cortex. Seizures did not respond to intravenous anti-epileptic drugs
(AEDs) but were controlled by steroid therapy.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy prevalence in Multiple Sclerosis (MS) patients is
signiﬁcantly larger that in general population, ranging from 2% to
5%.1,2 Epilepsy, associated with other symptoms, may affect
patients during early and chronic phases of the disease. However,
a causative link is difﬁcult to establish as many of earlier studies
neither mention the diagnostic criteria used to classify affected
patients, nor they provide detailed description of seizures and
clear anatomo-electroclinical correlations between ictal semi-
olgy and imaging.2 There has also been confusion between
epilepsy and non-epileptic paroxysmal tonic ﬁts arising from
brainstem or spinal lesions.3 Despite these considerations, there
is a small group of patients in which a causal association between
MS and epileptic seizures has been demonstrated.4–8 Rarely,
seizures have been described as the only manifestation of a
disease relapse.4–6
We describe a patient suffering from clinically deﬁned MS in
which focal sensory-motor status was the only manifestation of
a disease relapse due to a new small intra-cortical plaque.
An extensive neurophysiological and multimodal fMRI study
was performed to establish the causative role of the cortical
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The patient was a 42-year old manwith a 13-year history of MS
and minimal disability (Kurtzke’s Expanded Disability Status
Scale = 1). A previous diagnosis of relapsing-remitting MS was
formulated according to McDonald’s criteria.9 CSF examination
demonstrated oligoclonal bands. Patient’s last disease relapse
(right limbs sensory deﬁcit and weakness) dated 1-year back.
One month before presentation, the patient began complaining
paroxysmal attacks lasting seconds to minutes characterized by
stiffness and jerks of the left leg. Frequency and duration of these
episodes progressively increased up to 20–40 attacks/day ﬁnally
evolving into two generalized tonic–clonic convulsions. At
admission paroxysmal motor events were characterized by
involuntary contraction of the left foot with a dystonic attitude,
followed by clonic leg movements. The attacks occurred at rest
every 10–15 min and they could also be triggered by tactile stimuli
applied to the sole of the left foot and by voluntary or passive
movements of the left foot.
To ascertain the epileptic origin of the patient’s ﬁts, we
performed a video-polygraphic recording (Fig. 1): 24 events were
observed. Interictal EEG showed the presence of theta activities
and sharp waves at the vertex region. A rhythmic poly-spikes
discharge was observed in association with left tibialis anterior
muscle tonic–clonic contraction.
The patient underwent brain MRI (3-T Philips) that showed the
presence of one small non-enhancing intra-cortical lesion in the
right paracentral lobule, thatwas absent in a 3months earlier brainvier Ltd. All rights reserved.
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Fig. 1. Video-polygraphic monitoring: low-voltage de-synchronization of EEG activity (red arrow) precede the EMG tonic activity. Then the tonic muscle contraction is
associated with fast rhythmic discharge at the vertex region. Finally, the clonic phase of left Tibialis anterior muscle contraction is associated with theta activity in the same
EEG derivation (b detail of a). The EEG trace does not show a clear spikes discharge at the onset of the EMG activity in accordancewith the deeply location of the epileptogenic
zone in the medial surface of the frontal lobe. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of the article.)
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patients at our clinic (Fig. 2).
3. Multimodal functional MRI study
To map the relationship between the seizures, the cortical
plaque and the left footmotor area, the patient underwent an EEG–
fMRI co-registration of ictal seizure activity as well as a fMRI
mapping of the foot motor and somato-sensory area. The study
was performedwhen patient’s seizures were characterized by only
a focal dystonic contraction of the foot with no other overt
movement. At this time seizures were not triggered by movement
but occurred after tactile stimulation of the sole of the foot.
Simultaneous co-registration of EEG and fMRI enables identi-
fying changes in cerebral blood oxygenation level-dependent(BOLD) signal related to speciﬁc EEG events, combining temporal
resolution of EEG with spatial resolution of fMRI. Scalp EEG was
recorded bymeans of a 32 channelsMRI-compatible EEG recording
system (Micromed, Italy). To remove pulse andmovement artifacts
during scanning two of these electrodes were used to record the
electrocardiogram (ECG) and electromyogram (EMG). The EMG
electrode was placed on the right abductor pollicis brevis muscle.
Functional data were acquired with a 3T Philips Achieva MR
system. Each BOLD-echoplanar volume consisted of 30 transverse
slices (TR = 3000ms; 64 64 in plane matrix; voxel size
4 mm 4 mm 4 mm). In addition, at the end of the functional
session a high-resolution T1-weighted image of the brain was
acquired to allow anatomical localization of activations. The volume
consisted of 170 sagittal slices (TR, 9.9 ms; TE, 4.6 ms; voxel size,
1 mm 1 mm 1 mm).
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Fig. 2.MRI pre- (a and b) and post- (c and d) disease relapse (axial FLAIR and saggital T2-weighted images). The two exams (at a 3 months interval) were acquired with the
same sequence protocol and with the same 3-T Philips Achieva scan. A new small intra-cortical lesion was evident in the right paracentral lobule (c and d – red arrow). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of the article.)
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volumes were collected in each scanning session. To map reﬂex
seizures an event-related data analysis was conducted on 3 events
versus rest (brief electrographic seizures induced by foot somato-
sensory stimulation); the EEG artifact induced by the magnetic
ﬁeld gradient was digitally removed off-line using an adaptive
ﬁlter (Micromed). Then the ﬁltered EEGwas reviewed and the time
of onset and duration of each electrographic seizure was marked.
To map the somato-sensory cortex an event-related analysis was
conducted on 6 events (tactile foot somato-sensory stimulation
without seizures compared versus rest). Each event was convolved
with the standard hemodynamic response function (HRF). To map
the foot motor area a blocked design was used to compare periods
of foot dorsi-ﬂexion versus rest.
fMRI data analysis was performed with SPM5 software (Well-
come Department of Imaging Neuroscience). A t-statistic was used
to determine signiﬁcance on a voxel-by-voxel basis and correlation
values were transformed into a normal distribution (Z-statistic).
We identiﬁed the single region of condition-associated BOLD
signal changes with a statistical threshold based on the amplitude
(p < .05, corrected for multiple comparisons).
fMRI results showed overlapping clusters for both the motor
and the somato-sensory stimulation located in the paracentral
lobule and surrounding the intra-cortical plaque. Moreover,
increased BOLD signal due to reﬂex seizures substantially over-lapped with the cortical regions activated during voluntary foot
movement and somato-sensory stimulation (Fig. 3). No cluster of
deactivations (BOLD signals decreases versus the resting condi-
tion) was observed near the lesion nor at distant localizations.
4. Treatment and follow-up
The patient was initially treated with i.v. diazepam (10 mg): the
seizure stopped but soon recurred after 30 min. We then adminis-
tered i.v. phenitoin (1000 mg bolus followed by 750 mg/die) with
serum concentration in the therapeutic range on the second day of
treatment. However, there was no change in seizure frequency
within the next 3 days, albeit seizures intensity and duration was
shorter. Steroid therapy i.v. (1000mgmetil-prednisolone) was then
startedwith amarked seizures reduction. Seizureswere completely
controlled after 5 days of steroid treatment. At discharge no anti-
epileptic drug (AED) was prescribed to the patient. At 30-day and 3-
month follow-up seizures did not recur. Video-polygraphic record-
ing showed no evidence of subclinical seizures or minor motor
events such as myoclonus. However, at 6 months of follow-up the
patient complainedofoccasional tonic–clonic seizures of the left leg.
A new brain MRI did not reveal new lesions and the patient was
scheduled with oral phenitoin (200 mg die) with complete seizure
control. At 1-year follow-up the patient is seizure free on phenitoin
200 mg.
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Fig. 3. fMRI results. (a) Functional map of the left foot motor area; block design; p < 0.05 corrected for multiple comparison; k > 5 voxels. (b) Functional map of the left foot
somato-sensory cortex; event-related design; p < 0.05 corrected for multiple comparison; k > 5 voxels. (c) Functional map of three reﬂex seizures induced by left foot
somato-sensory stimulation; event-related design; p < 0.05 corrected for multiple comparison; k > 5 voxels. Results are overlaid on the patient’s T1 sagittal image (x = 8).10
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This case report demonstrates that: (1) patient’s paroxysmal
motor events were of epileptic origin; (2) there was a causal
relationship between the intra-cortical plaque of the foot sensory-
motor area and patient’s seizures; (3) the focal motor status was
the only manifestation of a MS relapse.
In particular, we utilize multimodal imaging techniques to
study the BOLD correlates of reﬂex foot seizures and their
relationships with physiological motor and somato-sensory
functions. Indeed, few studies have focused on the BOLD correlates
of ictal activity (owing to seizure unpredictability and the
limitations of this technique), particularly in motor seizures, and
even fewer have so clearly deﬁned the relationship between the
epileptogenic zone (pathological activation), normal functional
anatomy (physiological activation) and structural lesion.
It is well known that cortical lesions constitute a substantial
part of total lesion load in MS patients.11,12 Despite this, few cases
have clearly documented a causal relationship between a cortical
lesion and seizures. Even more rare are descriptions of repeated
seizures/status epilepticus due to a MS relapse. We were able to
ﬁnd only two case reports of ‘epilepsia partialis continua’ triggered
by a new cortical inﬂammatory lesion involving the central
region.5,6 Accordingly to these reports, we considered the repeated
seizures of the patient as event-related. That is secondary to the
inﬂammatory lesion of the sensory-motor cortex. The question
remains as to whether it was the lesion itself or the oedema
accompanying the lesion thatwas responsible for the development
of the seizures.3 The intra-cortical plaque of the patient was small
and non-enhancing. This implies that even a small inﬂammatory
lesion if located in strategically brain regions (as it is the sensory-
motor cortex) can cause seizures or status epilepticus.4–6 The fact
that the patient’s lesion did not show contrast enhancement is
consistent with the time lag elapsed between symptom onset and
MR imaging. Indeed, the new brain MRI study was undertaken
about 40 days after the onset of focal seizures. Unfortunately the
patient was referred to our Hospital only when he developed a
secondarily generalized tonic–clonic seizure. This time lag
between symptom onset and MR imaging could explain the
absence of contrast enhancement (gadolinium). This fact could
also suggest that epileptogenesis developed after the acute phase
of the inﬂammatory lesion.Finally, seizures showed a poor response to a standard AED
therapy for status epilepticus. On the contrary, seizures control
was achieved after initiation of steroid treatment as for any other
MS relapse. The same lack of efﬁcacy of AEDs together with a
positive response of intravenous steroid therapy was reported
previously.4–8 These case reports, therefore, underlie the impor-
tance to start soon an anti-inﬂammatory therapy when there is
evidence that seizures are secondary to new cortical/subcortical
MS lesions.
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